Different Lipid Parameters in Predicting Clinical Outcomes in Chinese Statin-Naïve Patients After Coronary Stent

Li Zeng1,2, Ziwei Ye1, Ying Li2

  • 1Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.

Insights

Low-density lipoprotein cholesterol (LDL-C) is a better predictor of cardiovascular events than other lipid parameters in Chinese patients after percutaneous coronary intervention (PCI). This finding supports LDL-C as a key target for managing cardiovascular disease risk in this population.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Preventive Medicine

Background:

  • Low-density lipoprotein cholesterol (LDL-C) is a crucial surrogate marker for cardiovascular disease (CVD).
  • Previous studies identified various predictive lipid parameters, but validation in Chinese populations is limited.
  • Understanding lipid parameter predictability is vital for cardiovascular risk management post-percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To compare the predictive value of different lipid parameters for cardiovascular outcomes in Chinese patients who are statin-naïve and have undergone PCI.
  • To assess the relative predictive strength of LDL-C against other non-LDL-C lipid parameters for major adverse cardiovascular events (MACEs).

Main Methods:

  • Retrospective cohort study of 445 statin-naïve patients undergoing PCI for stable angina or acute coronary syndrome.
  • Patients were divided into tertiles based on lipid parameter levels.
  • Multivariate Cox proportional hazards regression was used to calculate hazard ratios (HRs) for MACEs.

Main Results:

  • Higher tertiles of LDL-C, LDL-C/HDL-C, atherosclerosis index, and non-HDL-C were significantly associated with increased MACE risk.
  • Specifically, the highest LDL-C tertile showed a 165% increase in MACE hazard (HR 2.65).
  • Lipoprotein (a) levels did not demonstrate a significant association with cardiovascular endpoints.

Conclusions:

  • LDL-C demonstrates superior predictive value for cardiovascular outcomes compared to non-LDL-C lipid parameters in Chinese statin-naïve patients post-PCI.
  • These findings reinforce the importance of LDL-C monitoring and management in this patient group.
  • Further research may explore the role of specific lipid ratios in cardiovascular risk stratification.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
409
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
100
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
76
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
453
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
319